- call +1-201-465-4211
- email sales@mrinsights.biz
Birth control medicine used by female.
Scope of the Report:
This report studies the Female Contraceptives market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Female Contraceptives market by product type and applications/end industries.
Need to avoid unwanted pregnancies, especially among the teenage women, is one of the major drivers for this market. Government initiatives, promoting the use of contraceptives to avoid unnecessary births, and health benefits from using contraceptives, have also been important factors, instrumental in market growth.
The global Female Contraceptives market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Female Contraceptives.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Contraceptive Drugs
Contraceptive Devices
Market Segment by Applications, can be divided into
Personal use
Hospital
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Female Contraceptives Market Overview
1.1 Product Overview and Scope of Female Contraceptives
1.2 Classification of Female Contraceptives by Types
1.2.1 Global Female Contraceptives Revenue Comparison by Types (2017-2023)
1.2.2 Global Female Contraceptives Revenue Market Share by Types in 2017
1.2.3 Contraceptive Drugs
1.2.4 Contraceptive Devices
1.3 Global Female Contraceptives Market by Application
1.3.1 Global Female Contraceptives Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Personal use
1.3.3 Hospital
1.4 Global Female Contraceptives Market by Regions
1.4.1 Global Female Contraceptives Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Female Contraceptives Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Female Contraceptives Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Female Contraceptives Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Female Contraceptives Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Female Contraceptives Status and Prospect (2013-2023)
1.5 Global Market Size of Female Contraceptives (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Female Contraceptives Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mayer Laboratories
2.2.1 Business Overview
2.2.2 Female Contraceptives Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Female Contraceptives Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Female Contraceptives Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva
2.5.1 Business Overview
2.5.2 Female Contraceptives Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Female Contraceptives Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Female Contraceptives Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lupin Pharmaceuticals
2.8.1 Business Overview
2.8.2 Female Contraceptives Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.9 Female Health Company
2.9.1 Business Overview
2.9.2 Female Contraceptives Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fuji Latex
2.10.1 Business Overview
2.10.2 Female Contraceptives Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
3 Global Female Contraceptives Market Competition, by Players
3.1 Global Female Contraceptives Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Female Contraceptives Players Market Share
3.2.2 Top 10 Female Contraceptives Players Market Share
3.3 Market Competition Trend
4 Global Female Contraceptives Market Size by Regions
4.1 Global Female Contraceptives Revenue and Market Share by Regions
4.2 North America Female Contraceptives Revenue and Growth Rate (2013-2018)
4.3 Europe Female Contraceptives Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Female Contraceptives Revenue and Growth Rate (2013-2018)
4.5 South America Female Contraceptives Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Female Contraceptives Revenue and Growth Rate (2013-2018)
5 North America Female Contraceptives Revenue by Countries
5.1 North America Female Contraceptives Revenue by Countries (2013-2018)
5.2 USA Female Contraceptives Revenue and Growth Rate (2013-2018)
5.3 Canada Female Contraceptives Revenue and Growth Rate (2013-2018)
5.4 Mexico Female Contraceptives Revenue and Growth Rate (2013-2018)
6 Europe Female Contraceptives Revenue by Countries
6.1 Europe Female Contraceptives Revenue by Countries (2013-2018)
6.2 Germany Female Contraceptives Revenue and Growth Rate (2013-2018)
6.3 UK Female Contraceptives Revenue and Growth Rate (2013-2018)
6.4 France Female Contraceptives Revenue and Growth Rate (2013-2018)
6.5 Russia Female Contraceptives Revenue and Growth Rate (2013-2018)
6.6 Italy Female Contraceptives Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Female Contraceptives Revenue by Countries
7.1 Asia-Pacific Female Contraceptives Revenue by Countries (2013-2018)
7.2 China Female Contraceptives Revenue and Growth Rate (2013-2018)
7.3 Japan Female Contraceptives Revenue and Growth Rate (2013-2018)
7.4 Korea Female Contraceptives Revenue and Growth Rate (2013-2018)
7.5 India Female Contraceptives Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Female Contraceptives Revenue and Growth Rate (2013-2018)
8 South America Female Contraceptives Revenue by Countries
8.1 South America Female Contraceptives Revenue by Countries (2013-2018)
8.2 Brazil Female Contraceptives Revenue and Growth Rate (2013-2018)
8.3 Argentina Female Contraceptives Revenue and Growth Rate (2013-2018)
8.4 Colombia Female Contraceptives Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Female Contraceptives by Countries
9.1 Middle East and Africa Female Contraceptives Revenue by Countries (2013-2018)
9.2 Saudi Arabia Female Contraceptives Revenue and Growth Rate (2013-2018)
9.3 UAE Female Contraceptives Revenue and Growth Rate (2013-2018)
9.4 Egypt Female Contraceptives Revenue and Growth Rate (2013-2018)
9.5 Nigeria Female Contraceptives Revenue and Growth Rate (2013-2018)
9.6 South Africa Female Contraceptives Revenue and Growth Rate (2013-2018)
10 Global Female Contraceptives Market Segment by Type
10.1 Global Female Contraceptives Revenue and Market Share by Type (2013-2018)
10.2 Global Female Contraceptives Market Forecast by Type (2018-2023)
10.3 Contraceptive Drugs Revenue Growth Rate (2013-2023)
10.4 Contraceptive Devices Revenue Growth Rate (2013-2023)
11 Global Female Contraceptives Market Segment by Application
11.1 Global Female Contraceptives Revenue Market Share by Application (2013-2018)
11.2 Female Contraceptives Market Forecast by Application (2018-2023)
11.3 Personal use Revenue Growth (2013-2018)
11.4 Hospital Revenue Growth (2013-2018)
12 Global Female Contraceptives Market Size Forecast (2018-2023)
12.1 Global Female Contraceptives Market Size Forecast (2018-2023)
12.2 Global Female Contraceptives Market Forecast by Regions (2018-2023)
12.3 North America Female Contraceptives Revenue Market Forecast (2018-2023)
12.4 Europe Female Contraceptives Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Female Contraceptives Revenue Market Forecast (2018-2023)
12.6 South America Female Contraceptives Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Female Contraceptives Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Female Contraceptives Picture
Table Product Specifications of Female Contraceptives
Table Global Female Contraceptives and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
